Unique Wealth LLC Purchases 676 Shares of Stryker Co. (NYSE:SYK)

Unique Wealth LLC boosted its position in shares of Stryker Co. (NYSE:SYK) by 11.0% in the fourth quarter, HoldingsChannel reports. The fund owned 6,823 shares of the medical technology company’s stock after purchasing an additional 676 shares during the quarter. Unique Wealth LLC’s holdings in Stryker were worth $2,457,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Dunhill Financial LLC increased its holdings in Stryker by 94.9% in the third quarter. Dunhill Financial LLC now owns 76 shares of the medical technology company’s stock valued at $27,000 after buying an additional 37 shares in the last quarter. Centennial Bank AR increased its stake in shares of Stryker by 106.7% in the 2nd quarter. Centennial Bank AR now owns 93 shares of the medical technology company’s stock valued at $32,000 after purchasing an additional 48 shares in the last quarter. Darwin Wealth Management LLC acquired a new position in Stryker in the 3rd quarter worth about $36,000. HBW Advisory Services LLC purchased a new position in Stryker during the third quarter worth approximately $42,000. Finally, Hara Capital LLC acquired a new stake in Stryker in the third quarter valued at approximately $42,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Stock Down 1.3 %

Stryker stock opened at $360.96 on Tuesday. The company has a market capitalization of $137.60 billion, a PE ratio of 38.69, a price-to-earnings-growth ratio of 2.82 and a beta of 0.95. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.22 and a current ratio of 1.91. Stryker Co. has a fifty-two week low of $307.23 and a fifty-two week high of $398.20. The firm has a 50 day moving average price of $375.28 and a 200 day moving average price of $358.09.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Tuesday, October 29th. The medical technology company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.77 by $0.10. The firm had revenue of $5.49 billion for the quarter, compared to the consensus estimate of $5.37 billion. Stryker had a return on equity of 23.07% and a net margin of 16.34%. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.46 EPS. Research analysts expect that Stryker Co. will post 12.06 earnings per share for the current year.

Stryker Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.84 per share. The ex-dividend date is Tuesday, December 31st. This is a positive change from Stryker’s previous quarterly dividend of $0.80. This represents a $3.36 dividend on an annualized basis and a yield of 0.93%. Stryker’s dividend payout ratio is 36.01%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on SYK. StockNews.com raised shares of Stryker from a “hold” rating to a “buy” rating in a report on Thursday, January 9th. Evercore ISI lifted their price objective on Stryker from $380.00 to $384.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Truist Financial increased their target price on Stryker from $380.00 to $409.00 and gave the company a “hold” rating in a report on Wednesday, December 18th. Royal Bank of Canada reiterated an “outperform” rating and set a $425.00 price target on shares of Stryker in a research report on Tuesday, January 7th. Finally, Wells Fargo & Company raised their price objective on Stryker from $405.00 to $427.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. Four research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. Based on data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average price target of $405.80.

Insider Buying and Selling at Stryker

In related news, CEO Kevin Lobo sold 57,313 shares of Stryker stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $368.70, for a total value of $21,131,303.10. Following the completion of the transaction, the chief executive officer now owns 100,027 shares in the company, valued at $36,879,954.90. The trade was a 36.43 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 5.90% of the stock is currently owned by corporate insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.